Evidence map›Paper›PMID 35984448›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2022

On-Demand Fully Enclosed Superhydrophobic-Optofluidic Devices Enabled by Microstereolithography.

Yu Chang, Mengdi Bao, Jacob Waitkus, Haogang Cai, Ke Du

Open access · greenAbstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yu ChangDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, New York 14623, United States.
Mengdi BaoDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, New York 14623, United States.
Jacob WaitkusDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, New York 14623, United States.
Haogang CaiTech4Health Institute and Department of Radiology, NYU Langone Health, New York, New York 10016, United States.ORCID 0000-0003-1700-2531
Ke DuDepartment of Mechanical Engineering, Rochester Institute of Technology, Rochester, New York 14623, United States.ORCID 0000-0002-6837-0927
Rochester Institute of Technology · US

Funding

Understand and Detect Sepsis: Pathogen Isolation, Biochemistry Assay, and Optofluidic SensingR35GM142763 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI DU, KE · 2021 to 2025
$2.0M
NIGMS NIH HHS R35 GM142763
6 · The paper itself

Abstract

Superhydrophobic surface-based optofluidics have been introduced to biosensors and unconventional optics with unique advantages, such as low light loss and power consumption. However, most of these platforms were made with planar-like microstructures and nanostructures, which may cause bonding issues and result in significant waveguide loss. Here, we introduce a fully enclosed superhydrophobic-based optofluidics system, enabled by a one-step microstereolithography procedure. Various microstructured cladding designs with a feature size down to 100 μm were studied and a "T-type" overhang design exhibits the lowest optical loss, regardless of the excitation wavelength. Surprisingly, the optical loss of superhydrophobic-based optofluidics is not solely decided by the solid area fraction at the solid/water/air interface, but also the cross-section shape and the effective cladding layer composition. We show that this fully enclosed optofluidic system can be used for CRISPR-labeled quantum dot quantification, intended for in vitro and in vivo CRISPR therapeutics.

Indexed as

Biosensing TechniquesMicrofluidic Analytical TechniquesNanostructuresHydrophobic and Hydrophilic InteractionsOptics and Photonics

Identifiers

PMID35984448
PMCPMC9897971
OpenAlexW4292367637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.